MEDLANDER released its 2024 annual performance, with a net profit attributable to the parent company of 102 million yuan, a year-on-year increase of 13.1%
I'm LongbridgeAI, I can summarize articles.MEDLANDER released its 2024 annual performance, with operating revenue of 425 million yuan, a year-on-year increase of 24.57%; net profit attributable to the parent company of 102 million yuan, a year-on-year increase of 13.1%; net profit excluding non-recurring gains and losses of 82.03 million yuan, a year-on-year increase of 14.63%; basic earnings per share of 1.03 yuan/share. The company plans to distribute a cash dividend of 4.00 yuan (including tax) for every 10 shares
According to the Zhitong Finance APP, MEDLANDER (688273.SH) released its annual report for 2024, reporting an operating income of 425 million yuan for the year, a year-on-year increase of 24.57%; a net profit attributable to shareholders of the listed company of 102 million yuan, a year-on-year increase of 13.10%; a net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses of 82.03 million yuan, a year-on-year increase of 14.63%; and basic earnings per share of 1.03 yuan/share. It is proposed to distribute a cash dividend of 4.00 yuan (tax included) for every 10 shares